Find any stock by ticker or company name
Barcha huquqlar himoyalangan.
NMS – Real vaqt narxi. Valyuta: USD
30.99
0.00 (0.00%)
Yopilishda: Mar 16, 2026, 4:00 PM EDT
LOUISVILLE, Ky. -- June 16, 2026, June 16, 2026 (GLOBE NEWSWIRE) -- Chronic pain is shaping how millions of Americans live, move, sleep, work, and recover. New findings from Confluent Health suggest the healthcare system may still be falling short in addressing it.
LONDON--(BUSINESS WIRE)--Confluent, an IBM Company and the data streaming pioneer, today announced new capabilities in Confluent Intelligence and Confluent Cloud that streamline how real-time artificial intelligence (AI) applications are built and secured. These updates remove the security and complexity barriers that stop organizations from moving AI workloads into the real world: Confluent unifies the AI life cycle with tools that developers already live in, integrating Apache Flink® pipeline.
SCOTTSDALE, Ariz., May 01, 2026 (GLOBE NEWSWIRE) -- Confluent Medical Technologies, Inc. (“Confluent”), a leading medical device and materials science contract manufacturer specializing in Nitinol and polymer components, today announced that Tom Testa, has been appointed as Chief Operating Officer ("COO") for the company, effective April 29th, 2026.
NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. (“Confluent” or the “Company”) (NASDAQ: CFLT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
NEW YORK, April 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. ("Confluent" or the "Company") (NASDAQ: CFLT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Confluent, Inc. (“Confluent” or the “Company”) (NASDAQ: CFLT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
International Business Machines Corp (NYSE:IBM) is expected to report first-quarter results largely in line with forecasts on April 22, but Bank of America is adjusting estimates following the earlier-than-expected closing of its Confluent acquisition The bank said it anticipates an “inline quarter,” with recently acquired Confluent contributing roughly $50 million in revenue during the period after the deal closed on March 17, about one quarter earlier than previously assumed. Bank of America said IBM is likely to keep its full-year 2026 guidance unchanged, as management is expected to offset near-term dilution from the acquisition with a combination of additional revenue contribution and cost synergies.